Literature DB >> 28705076

Elucidation of stable intermediates in urea-induced unfolding pathway of human carbonic anhydrase IX.

Amresh Prakash1, Gunjan Dixit1, Naveen Kumar Meena1, Ruhar Singh1, Poonam Vishwakarma1, Smriti Mishra1, Andrew M Lynn1.   

Abstract

Human carbonic anhydrase IX (CAIX) has evolved as a promising biomarker for cancer prognosis, due to its overexpression in various cancers and restricted expression in normal tissue. However, limited information is available on its biophysical behavior. The unfolding of CAIX in aqueous urea solution was studied using all-atom molecular dynamics simulation approach. The results of this study revealed a stable intermediate state along the unfolding pathway of CAIX. At intermediate concentrations of urea (2.0-4.0 M), the protein displays a native-like structure with a large population of its secondary structure and hydrophobic contacts remaining intact in addition to small confined overall motions. Beyond 4.0 M urea, the unfolding is more gradual and at 8.0 M urea the structure is largely collapsed due to the solvent effect. The hydrophobic contact analysis suggests that the contact in terminal α-helices is separated initially which propagates in the loss of contacts from centrally located β-sheets. The reduction of 60-65% tertiary contacts in 7.0-8.0 M urea suggested the presence of residual structure in unfolded state and is confirmed with structural snap shot. Free energy landscape analysis suggested that unfolding of CAIX exists through the different intermediate states.

Entities:  

Keywords:  MD simulation; carbonic anhydrase IX; protein unfolding; stable intermediate

Mesh:

Substances:

Year:  2017        PMID: 28705076     DOI: 10.1080/07391102.2017.1355847

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  7 in total

1.  In silico characterization, docking, and simulations to understand host-pathogen interactions in an effort to enhance crop production in date palms.

Authors:  Meshari Alazmi; N Alshammari; Naimah A Alanazi; Abdel Moneim E Sulieman
Journal:  J Mol Model       Date:  2021-11-03       Impact factor: 1.810

2.  Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease.

Authors:  Chandra Bhushan Mishra; Shruti Shalini; Siddharth Gusain; Amresh Prakash; Jyoti Kumari; Shikha Kumari; Anita Kumari Yadav; Andrew M Lynn; Manisha Tiwari
Journal:  RSC Adv       Date:  2020-05-05       Impact factor: 3.361

3.  Targeting virus-host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19.

Authors:  Jitendra Subhash Rane; Preeti Pandey; Aroni Chatterjee; Rajni Khan; Abhijeet Kumar; Amresh Prakash; Shashikant Ray
Journal:  J Biomol Struct Dyn       Date:  2020-07-20

4.  Structural and thermodynamic analysis of factors governing the stability and thermal folding/unfolding of SazCA.

Authors:  Shashi Kumar; Parag A Deshpande
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

5.  Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach.

Authors:  Satabdi Saha; Rajat Nandi; Poonam Vishwakarma; Amresh Prakash; Diwakar Kumar
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

6.  Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction.

Authors:  Ruhar Singh; Abhijeet Kumar; Jitendra Subhash Rane; Rajni Khan; Garima Tripathi; Amrendra K Ajay; Amresh Prakash; Shashikant Ray
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

7.  "Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CLpro and PLpro."

Authors:  Deep Bhowmik; Ravi Datta Sharma; Amresh Prakash; Diwakar Kumar
Journal:  J Mol Struct       Date:  2021-02-15       Impact factor: 3.196

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.